Subarachnoid hemorrhage
Subarachnoid hemorrhage (SAH) is a type of hemorrhagic cerebrovascular disease, which is divided into primary and secondary types. Primary subarachnoid hemorrhage is caused by ruptured blood vessels on the surface and base of the brain, and blood flows directly into the subarachnoid space. It is also called spontaneous SAH. Secondary SAH is caused by brain parenchymal or ventricular hemorrhage, traumatic subdural or epidural hemorrhage flowing into the subarachnoid space. Subarachnoid hemorrhage is one of the most common emergencies in neurology, and the incidence rate accounts for 6% to 10% of acute cerebrovascular diseases.
-
Site of disease:
Brain -
Infectious :
Not contagious -
Frequent population:
It is more common in young adults aged 30 to 40, and some... -
Related symptoms:
Symptoms of meningeal irritation Localizing neurological signs Hemiplegia Epilepsy and epileptic seizures Headache
Related Drugs
Nimodipine extended-release tablets
Indication: Used for ischemic cerebrovascular disease, migraine, cerebral vasospasm caused by mild subarachnoid hemorrhage, sudden deafness and mild to moderate hypertension.
Manufacturer:
Hubei Sihuan Pharmaceutical Co., Ltd.
Nimodipine Dispersible Tablets
Indication: It is suitable for improving blood circulation in the recovery period of cerebral vasospasm after subarachnoid hemorrhage of various reasons and acute cerebrovascular disease.
Manufacturer:
Jinhua Enterprise (Group) Co., Ltd. Xi'an Jinhua Pharmaceutical Factory
Nitrendipine
Indication: Hypertension, subarachnoid hemorrhage.
Manufacturer:
Shaanxi XIYUE Pharmaceutical Co., Ltd.
Nimodipine Injection
Indication: It is suitable for improving blood circulation in the recovery period of cerebral vasospasm after subarachnoid hemorrhage of various reasons and acute cerebrovascular disease.
Manufacturer:
Shandong Fenghuang Pharmaceutical Co., Ltd.
Fasudil Hydrochloride Injection
Indication: Improvement of symptoms of ischemic cerebrovascular disease caused by cerebral vasospasm after subarachnoid hemorrhage.
Manufacturer:
Shanxi PUDE Pharmaceutical Co., Ltd.
Ozagrel Sodium Injection
Indication: Used to treat acute thrombotic cerebral infarction and movement disorders associated with cerebral infarction, and to improve cerebral vasospasm and contraction and concurrent cerebral ischemia symptoms after subarachnoid hemorrhage surgery.
Ozagrel Sodium Injection
Indication: Used to treat acute thrombotic cerebral infarction and movement disorders associated with cerebral infarction, and to improve cerebral vasospasm and contraction and concurrent cerebral ischemia symptoms after subarachnoid hemorrhage surgery.
Manufacturer:
Changchun Extrawell Pharmaceutical Co., Ltd.
Ozagrel Sodium Injection
Indication: Used to treat acute thrombotic cerebral infarction and movement disorders associated with cerebral infarction, and to improve cerebral vasospasm and contraction and concurrent cerebral ischemia symptoms after subarachnoid hemorrhage surgery.
Manufacturer:
Changchun Extrawell Pharmaceutical Co., Ltd.
Nimodipine extended-release tablets
Indication: Used for ischemic cerebrovascular disease, migraine, cerebral vasospasm caused by mild subarachnoid hemorrhage, sudden deafness and mild to moderate hypertension.
Manufacturer:
Qilu Pharmaceutical Co., Ltd.